How We Manage Gastrointestinal Symptoms During Oral Immunotherapy Through a Shared Decision-Making Process-A Practical Guide for the Community Practitioner

被引:12
作者
Chua, Gilbert T. [1 ,2 ,3 ,9 ]
Chan, Edmond S. [4 ,5 ,6 ]
Invik, Rosemary [7 ]
Soller, Lianne [4 ,5 ,6 ]
Avinashi, Vishal [5 ,6 ,8 ]
Erdle, Stephanie C. [4 ]
Wong, Tiffany [4 ]
Cook, Victoria E. [4 ,7 ]
Mak, Raymond [4 ,5 ,6 ]
Cameron, Scott B. [4 ,7 ]
机构
[1] Univ Hong Kong, Li Ka Shing Fac Med, Dept Paediat & Adolescent Med, Hong Kong, Peoples R China
[2] Union Hosp, Allergy Ctr, Hong Kong, Peoples R China
[3] Univ Hong Kong, Shenzhen Hosp, Dept Paediat, Shenzhen, Peoples R China
[4] Univ British Columbia, Dept Pediat, Div Allergy & Immunol, Vancouver, BC, Canada
[5] British Columbia Childrens Hosp Res Inst, Vancouver, BC, Canada
[6] Univ British Columbia, Vancouver, BC, Canada
[7] Community Allergy Clin, Victoria, BC, Canada
[8] BC Childrens Hosp, Dept Pediat, Div Gastroenterol Hepatol & Nutr, Vancouver, BC, Canada
[9] Univ Hong Kong, Queen Mary Hosp, Li Ka Shing Fac Med, Dept Paediat & Adolescent Med, 1-F,New Clin Bldg,102 Pokfulam Rd, Hong Kong, Peoples R China
关键词
Gastrointestinal symptoms; Oral immunotherapy; Eosinophilic gastrointestinal diseases; Shared decision-making; EOSINOPHILIC ESOPHAGITIS;
D O I
10.1016/j.jaip.2022.11.015
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Allergists addressing gastrointestinal (GI) symptoms during oral immunotherapy (OIT) may be biased toward diagnoses related to OIT; however, non-OIT causes may occur. Although there is currently a lack of robust data for evidence-based treatment recommendations, we provide 3 real-world illustrative cases along with a proposed management algorithm for GI symptoms encountered during OIT. This algorithm was developed because of a significant clinical need, given the number of new-to-OIT providers that include practicing allergists, trainees transitioning into practice, and allied health care providers who manage GI symptoms in OIT patients. We developed the algorithm based on the opinions of community and academic allergy clinics across Canada with significant clinical experience offering infant, preschool, and school-aged OIT patients, with gastroenterologist input. Further research is needed to fill the knowledge gaps in the management of GI symptoms during OIT before formal recommendations can be suggested. (c) 2022 American Academy of Allergy, Asthma & Immunology (J Allergy Clin Immunol Pract 2023;11:1049-55)
引用
收藏
页码:1049 / 1055
页数:7
相关论文
共 19 条
[1]   How to Incorporate Oral Immunotherapy into Your Clinical Practice [J].
Abrams, Elissa M. ;
Erdle, Stephanie C. ;
Cameron, Scott B. ;
Soller, Lianne ;
Chan, Edmond S. .
CURRENT ALLERGY AND ASTHMA REPORTS, 2021, 21 (04)
[2]  
Alfadda Abdulrahman A, 2011, Therap Adv Gastroenterol, V4, P301, DOI 10.1177/1756283X10392443
[3]   Weighing the benefits and risks of oral immunotherapy in clinical practice [J].
Anagnostou, Aikaterini .
ALLERGY AND ASTHMA PROCEEDINGS, 2021, 42 (02) :118-123
[4]   CSACI guidelines for the ethical, evidence-based and patient-oriented clinical practice of oral immunotherapy in IgE-mediated food allergy [J].
Begin, P. ;
Chan, E. S. ;
Kim, H. ;
Wagner, M. ;
Cellier, M. S. ;
Favron-Godbout, C. ;
Abrams, E. M. ;
Ben-Shoshan, M. ;
Cameron, S. B. ;
Carr, S. ;
Fischer, D. ;
Haynes, A. ;
Kapur, S. ;
Primeau, M. N. ;
Upton, J. ;
Vander Leek, T. K. ;
Goetghebeur, M. M. .
ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2020, 16 (01)
[5]   Eosinophilic Esophagitis Symptom Scores Are High in Children Without Eosinophilic Disease [J].
Bose, Paroma ;
Albright, Eric ;
Idrees, Muhammad T. ;
Perkins, Anthony ;
Sawyers, Cindy ;
Gupta, Sandeep K. ;
Hon, Emily C. .
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2022, 74 (03) :396-401
[6]   Management of Eosinophilic Esophagitis During Oral Immunotherapy [J].
Chu, Derek K. ;
Spergel, Jonathan M. ;
Vickery, Brian P. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (09) :3282-3287
[7]   Toxicity of long-term use of proton pump inhibitors in children [J].
De Bruyne, Pauline ;
Ito, Shinya .
ARCHIVES OF DISEASE IN CHILDHOOD, 2018, 103 (01) :78-82
[8]   Primary eosinophilic gastrointestinal disorders in children who have received food oral immunotherapy [J].
Echeverria-Zudaire, L. A. ;
Fernandez-Fernandez, S. ;
Rayo-Fernandez, A. ;
Munoz-Archidona, C. ;
Checa-Rodriguez, R. .
ALLERGOLOGIA ET IMMUNOPATHOLOGIA, 2016, 44 (06) :531-536
[9]   Risk Factors and Treatment Outcomes for Oral Immunotherapy-Induced Gastrointestinal Symptoms and Eosinophilic Responses (OITIGER) [J].
Goldberg, Michael R. ;
Nachshon, Liat ;
Levy, Michael B. ;
Elizur, Arnon ;
Katz, Yitzhak .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2020, 8 (01) :125-131
[10]  
Goldberg MR, 2017, J ALLERGY CLIN IMMUN, V139, P4